EXEMASIN - VIT

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

EXEMESTANE

Available from:

VITAMED PHARMACEUTICAL INDUSTRIES LTD

ATC code:

L02BG06

Pharmaceutical form:

FILM COATED TABLETS

Composition:

EXEMESTANE 25 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

GENEPHARM S.A., GREECE

Therapeutic area:

EXEMESTANE

Therapeutic indications:

Exemasin-VIT is indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone.Exemasin-VIT is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies. Exemasin-VIT is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Authorization date:

2021-06-30

Patient Information leaflet

Patient leaflet in accordance with the Pharmacists'
Regulations (Preparations) - 1986
This medicine can be sold with a physician's prescription
only
Exemasin-Vit, 25 mg,
Coated tablets
The active ingredient and its quantity:
Each coated tablet contains: exemestane 25 mg.
Inactive ingredients and allergens in the medicine- see section 6
"Additional
information" and in section 2 "Important information about some of the
ingredients of this medicine".
Read the entire leaflet carefully before using this medicine. This
leaflet contains concise
information about this medicine. If you have any further questions,
refer to the doctor or
pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It may
harm them, even if it seems to you that their illness is similar to
yours.
This medicine is not intended for children.
1.
What is the medicine intended for?
Exemasin-Vit is used to treat hormone dependent early breast cancer in
postmenopausal
women, after they have completed 2-3 years of treatment with the
medicine tamoxifen.
Additionally, Exemasin-Vit is used for the treatment of hormone
dependent advanced breast
cancer in women in postmenopausal status (natural or induced), whose
disease has
progressed following a single hormonal (anti-estrogen) therapy or
several hormonal
therapies.
Therapeutic group: Steroidal inhibitors of the enzyme aromatase,
anti-neoplastic (anti-
cancer) agents.
Exemasin-Vit belongs to a group of medicines known as aromatase
inhibitors; aromatase is
an enzyme required for the production of the female sex hormones -
estrogens, especially in
postmenopausal women. Reduction in estrogen levels in the body is a
way of treating
hormone dependent breast cancer.
2. Before using this medicine
Do not use this medicine if you:
•
Are or have previously been hypersensitive (allergic) to the active
ingredient
(exemestane) or to any of the other ingredients this medicine contains
(see section
6 "Additional information").
•
Are pregnant, likely to be pregnant or breastfeedi